|
|
|
Volumn 88, Issue suppl 5, 2005, Pages
|
|
Monitoring of Risedronate by biochemical bone markers in clinical practice.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
BIOLOGICAL MARKER;
BONE DENSITY CONSERVATION AGENT;
DRUG DERIVATIVE;
ETIDRONIC ACID;
OSTEOCALCIN;
PEPTIDE FRAGMENT;
PROCOLLAGEN;
PROCOLLAGEN TYPE I CARBOXY TERMINAL PEPTIDE;
RISEDRONIC ACID;
UNCLASSIFIED DRUG;
ARTICLE;
BONE;
BONE DENSITY;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG MONITORING;
FEMALE;
HUMAN;
MIDDLE AGED;
OSTEOLYSIS;
PATHOLOGY;
POSTMENOPAUSE OSTEOPOROSIS;
TIME;
TREATMENT OUTCOME;
VITAMIN K DEFICIENCY;
ALKALINE PHOSPHATASE;
BIOLOGICAL MARKERS;
BONE AND BONES;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
BONE RESORPTION;
DRUG MONITORING;
ETIDRONIC ACID;
FEMALE;
HUMANS;
MIDDLE AGED;
OSTEOCALCIN;
OSTEOPOROSIS, POSTMENOPAUSAL;
PEPTIDE FRAGMENTS;
PROCOLLAGEN;
TIME FACTORS;
TREATMENT OUTCOME;
VITAMIN K DEFICIENCY;
|
|
EID: 34248592208
PISSN: 01252208
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
